Crossmark

Obinutuzumab en el tratamiento de la glomerulonefritis membranosa PLA2R positiva resistente a tratamiento

Crossref DOI link: https://doi.org/10.1016/j.nefro.2023.03.003

Published Print: 2024-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

de la Prada Álvarez, Francisco José

Cintra Cabrera, Melissa

Almenara Tejederas, Marina

Burgos Martin, Javier

Alonso García, Fabiola

Salgueira Lazo, Mercedes
License Information

Text and Data Mining valid from 2024-03-01

Text and Data Mining valid from 2024-03-01

Version of Record valid from 2023-03-15
More Information

This article is maintained by: Elsevier

Article Title: Obinutuzumab en el tratamiento de la glomerulonefritis membranosa PLA2R positiva resistente a tratamiento

Journal Title: Nefrología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.nefro.2023.03.003

Content Type: simple-article

Copyright: © 2023 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U.